Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of nitric oxide in patients with respiratory syncytial virus and bronchiolitis

Next Previous
Trial Profile

Phase II trial of nitric oxide in patients with respiratory syncytial virus and bronchiolitis

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Bronchiolitis; Respiratory syncytial virus infections
  • Focus Therapeutic Use

    • Most Recent Events

    • 15 Jul 2019 According to a Beyond Air media release, the company has changed its name from AIT Therapeutics to Beyond Air.
    • 04 Jun 2019 According to an AIT Therapeutics media release, the company announced that the proceeds of the PIPE financing will be used to complete this trial.
    • 21 Apr 2015 Data will be presented at the American Thoracic Society 2015 International Conference, according to an Advanced Inhalation Therapies media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top